The most noteworthy gene is L3MBTL3 (PIP = 1) which has not previously been linked to prostate cancer but has been reported to be associated with height (Gudbjartsson et al., 2008), type 2 diabetes (Vujkovic et al., 2020), and body mass index (Pulit et al., 2019), all suspected risk factors of prostate cancer (Table 4). Here, L3MBTL3 is linked to prostate cancer.